Drug Absorption Studies: In Situ, In Vitro and In Silico Models
This Book serves to highlight the mechanisms related to the low intestinal drug absorption, the strategies to overcome the obstacles or intestinal drug absorption, and in situ, in vitro, and in silico methodologies to predict to intestinal drug absorption. This Book presents a series of drug absorpt...
Saved in:
| Other Authors: | |
|---|---|
| Format: | Electronic Book Chapter |
| Language: | English |
| Published: |
Basel, Switzerland
MDPI - Multidisciplinary Digital Publishing Institute
2021
|
| Subjects: | |
| Online Access: | DOAB: download the publication DOAB: description of the publication |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000naaaa2200000uu 4500 | ||
|---|---|---|---|
| 001 | doab_20_500_12854_77071 | ||
| 005 | 20220111 | ||
| 003 | oapen | ||
| 006 | m o d | ||
| 007 | cr|mn|---annan | ||
| 008 | 20220111s2021 xx |||||o ||| 0|eng d | ||
| 020 | |a books978-3-0365-2460-3 | ||
| 020 | |a 9783036524610 | ||
| 020 | |a 9783036524603 | ||
| 040 | |a oapen |c oapen | ||
| 024 | 7 | |a 10.3390/books978-3-0365-2460-3 |c doi | |
| 041 | 0 | |a eng | |
| 042 | |a dc | ||
| 072 | 7 | |a M |2 bicssc | |
| 072 | 7 | |a KNDP |2 bicssc | |
| 100 | 1 | |a Song, Im-Sook |4 edt | |
| 700 | 1 | |a Song, Im-Sook |4 oth | |
| 245 | 1 | 0 | |a Drug Absorption Studies: In Situ, In Vitro and In Silico Models |
| 260 | |a Basel, Switzerland |b MDPI - Multidisciplinary Digital Publishing Institute |c 2021 | ||
| 300 | |a 1 electronic resource (171 p.) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
| 520 | |a This Book serves to highlight the mechanisms related to the low intestinal drug absorption, the strategies to overcome the obstacles or intestinal drug absorption, and in situ, in vitro, and in silico methodologies to predict to intestinal drug absorption. This Book presents a series of drug absorption studies and related technologies that predict intestinal permeation of drugs that govern the pharmacokinetic features of therapeutic drugs. It also contains the mechanistic understanding regarding the first-pass metabolism and intestinal efflux that modulate the pharmacokinetics of drug and suggest the formulation strategies to enhance the bioavailability of investigated drugs. | ||
| 540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
| 546 | |a English | ||
| 650 | 7 | |a Medicine |2 bicssc | |
| 650 | 7 | |a Pharmaceutical industries |2 bicssc | |
| 653 | |a rebamipide | ||
| 653 | |a nanocrystals | ||
| 653 | |a oral mucositis | ||
| 653 | |a hydrogel | ||
| 653 | |a endocytosis | ||
| 653 | |a enoxaparin | ||
| 653 | |a lipid-polymer hybrid nanoparticles | ||
| 653 | |a oral | ||
| 653 | |a intestinal absorption | ||
| 653 | |a naftidrofuryl oxalate | ||
| 653 | |a solubility | ||
| 653 | |a permeability | ||
| 653 | |a dissolution profiles | ||
| 653 | |a pharmaceutical availability | ||
| 653 | |a BCS drug classification | ||
| 653 | |a non-sink condition | ||
| 653 | |a solubility-permeability interplay | ||
| 653 | |a unstirred water layer | ||
| 653 | |a poorly soluble drugs | ||
| 653 | |a solubilizer additive | ||
| 653 | |a phenylketonuria | ||
| 653 | |a l-phenylalanine ammonia-lyase | ||
| 653 | |a enzyme | ||
| 653 | |a kinetics | ||
| 653 | |a catabolism disorder | ||
| 653 | |a biomedical drug | ||
| 653 | |a P-glycoprotein | ||
| 653 | |a breast cancer resistance protein | ||
| 653 | |a LY335979 | ||
| 653 | |a WK-X-34 | ||
| 653 | |a in vivo-in vitro correlation | ||
| 653 | |a lipolysis-permeation | ||
| 653 | |a lipid-based drug delivery system | ||
| 653 | |a PermeaPad | ||
| 653 | |a cinnarizine | ||
| 653 | |a lipolysis | ||
| 653 | |a amorphous solid dispersion | ||
| 653 | |a candesartan Cilexetil | ||
| 653 | |a PVPK30 | ||
| 653 | |a pH-modulation | ||
| 653 | |a spray drying | ||
| 653 | |a bioavailability | ||
| 653 | |a nasal administration | ||
| 653 | |a spray-drying | ||
| 653 | |a chitosan | ||
| 653 | |a microsphere | ||
| 653 | |a meloxicam | ||
| 653 | |a silymarin | ||
| 653 | |a D-α-Tocopherol polyethylene glycol 1000 succinate (TPGS) | ||
| 653 | |a liver distribution | ||
| 653 | |a acetaminophen-induced hepatotoxicity | ||
| 653 | |a extra virgin olive oil | ||
| 653 | |a secoiridoids | ||
| 653 | |a metabolism | ||
| 653 | |a phenolic compounds | ||
| 653 | |a intestinal permeability | ||
| 653 | |a drug-phytochemical interaction | ||
| 653 | |a hepatic metabolism | ||
| 653 | |a mixed inhibition | ||
| 653 | |a quercetin | ||
| 653 | |a repaglinide | ||
| 856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/4689 |7 0 |z DOAB: download the publication |
| 856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/77071 |7 0 |z DOAB: description of the publication |